Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via A. Moro, 53100 Siena, Italy.
Eur J Med Chem. 2012 Dec;58:30-43. doi: 10.1016/j.ejmech.2012.09.035. Epub 2012 Oct 3.
Within our studies on structure-activity relationships of 4-quinolone-3-carboxamides as cannabinoid ligands, a new series of compounds characterized by a fluoro or phenylthio group at 7-position and different substituents at N1 and carboxamide nitrogen were synthesized and evaluated for their binding ability to cannabinoid type 1 (CB1) and type 2 (CB2) receptors. Most of the compounds showed affinity for one or both cannabinoid receptors at nanomolar concentration, with K(i)(CB1) and K(i)(CB2) values ranging from 2.45 to >10,000 nM and from 0.09 to 957 nM, respectively. The N-(3,4-dichlorobenzyl)amide derivatives 27 and 40 displayed relatively low affinity, but high selectivity towards the CB1 receptor. Compounds 4 and 40, a CB2 and a CB1 ligand, respectively, behaved as partial agonists in the [(35)S]GTPγS assay. They showed very low permeability through (MDCK-MDR1) cells and might, therefore, represent possible lead structures for further optimization in the search for cannabinoid ligands unable to cross the blood-brain barrier.
在我们对 4-喹诺酮-3-羧酰胺作为大麻素配体的结构-活性关系的研究中,合成了一系列新的化合物,其特征是在 7-位具有氟或苯硫基以及在 N1 和羧酰胺氮上具有不同取代基。这些化合物的结合能力被评估为对大麻素类型 1(CB1)和类型 2(CB2)受体。大多数化合物在纳摩尔浓度下对一种或两种大麻素受体表现出亲和力,Ki(CB1)和 Ki(CB2)值分别为 2.45 至>10,000 nM 和 0.09 至 957 nM。N-(3,4-二氯苄基)酰胺衍生物 27 和 40 对 CB1 受体表现出相对较低的亲和力,但具有较高的选择性。化合物 4 和 40,分别为 CB2 和 CB1 配体,在[(35)S]GTPγS 测定中表现为部分激动剂。它们在 (MDCK-MDR1) 细胞中的通透性非常低,因此可能代表进一步优化以寻找不能穿过血脑屏障的大麻素配体的潜在先导结构。